News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Biocryst Pharmaceuticals Provides Corporate Update and Reports First Quarter 2011 Financial Results
May 4, 2011
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) today announced financial results for the first quarter ended March 31, 2011.
Twitter
LinkedIn
Facebook
Email
Print
Earnings
BioCryst Pharmaceuticals, Inc.
MORE ON THIS TOPIC
Legal
Delaware Court Denies Pfizer’s Bid to Block Novo-Metsera Deal
November 6, 2025
·
2 min read
·
Tristan Manalac
Obesity
Novo’s Metsera Bid Attracts FTC Scrutiny As Pfizer Matches $10B Offer
November 6, 2025
·
3 min read
·
Tristan Manalac
Business
Basel Life Sciences Scene Embraces International Companies, Startups
November 6, 2025
·
6 min read
·
Angela Gabriel
Obesity
Is Metsera Worth The Fuss?
November 5, 2025
·
4 min read
·
Annalee Armstrong
